Dalian BIO-CHEM Co Ltd
SSE:603360
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
8.16
27.43
|
| Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Dalian BIO-CHEM Co Ltd
Total Receivables
Dalian BIO-CHEM Co Ltd
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
Dalian BIO-CHEM Co Ltd
SSE:603360
|
Total Receivables
¥464.3m
|
CAGR 3-Years
45%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
Zhejiang Juhua Co Ltd
SSE:600160
|
Total Receivables
¥3.5B
|
CAGR 3-Years
25%
|
CAGR 5-Years
15%
|
CAGR 10-Years
13%
|
|
|
Hengli Petrochemical Co Ltd
SSE:600346
|
Total Receivables
¥14.3B
|
CAGR 3-Years
22%
|
CAGR 5-Years
12%
|
CAGR 10-Years
44%
|
|
|
Satellite Chemical Co Ltd
SZSE:002648
|
Total Receivables
¥2.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
11%
|
CAGR 10-Years
10%
|
|
|
Jiangsu Eastern Shenghong Co Ltd
SZSE:000301
|
Total Receivables
¥5.5B
|
CAGR 3-Years
87%
|
CAGR 5-Years
54%
|
CAGR 10-Years
39%
|
|
|
Rongsheng Petrochemical Co Ltd
SZSE:002493
|
Total Receivables
¥16.2B
|
CAGR 3-Years
51%
|
CAGR 5-Years
35%
|
CAGR 10-Years
21%
|
|
Dalian BIO-CHEM Co Ltd
Glance View
Dalian BIO-CHEM Co Ltd, rooted in the bustling port city of Dalian, China, specializes in the innovative production and distribution of fine chemicals and intermediates. Founded with the intent to bridge advanced chemical solutions with practical applications, the company has carved a niche in the global market for its high-quality, sustainable chemical products that serve various industries, including pharmaceuticals, agriculture, and materials science. At the heart of Dalian BIO-CHEM's operations lies its cutting-edge research and development team, consistently pushing the boundaries to create environmentally friendly solutions. These efforts have not only bolstered its reputation but also expanded its reach across continents, as it meets the ever-evolving demands of a global clientele. To drive its revenue, Dalian BIO-CHEM capitalizes on a strategic business model that blends large-scale production efficiencies with bespoke chemical solutions. By maintaining robust relationships with raw material suppliers, the company ensures a stable production pipeline, allowing it to offer competitive pricing without compromising on quality. Its earnings are primarily generated through contracts with multinational corporations and smaller businesses that rely on steady supplies of specialty chemicals. Further diversification into custom synthesis services has enabled Dalian BIO-CHEM to address unique client needs, enhancing customer loyalty and expanding its market presence. This strategic agility positions the company not merely as a supplier, but as a trusted partner in the innovation ecosystem of chemical manufacturing.
See Also
What is Dalian BIO-CHEM Co Ltd's Total Receivables?
Total Receivables
464.3m
CNY
Based on the financial report for Sep 30, 2024, Dalian BIO-CHEM Co Ltd's Total Receivables amounts to 464.3m CNY.
What is Dalian BIO-CHEM Co Ltd's Total Receivables growth rate?
Total Receivables CAGR 5Y
22%
Over the last year, the Total Receivables growth was 13%. The average annual Total Receivables growth rates for Dalian BIO-CHEM Co Ltd have been 45% over the past three years , 22% over the past five years .
You don't have any saved screeners yet
